Syndax Pharmaceuticals Inc (SNDX) Insider Trading
- $2,382,762.55
- $35,161,040.41
- Feb. 9, 2026
- Michael A Metzger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 9, 2026 | CFO | 3,410 | $21.03 | Sell | $71,712.30 | |
| Feb. 9, 2026 | CEO | 17,159 | $21.03 | Sell | $360,853.77 | |
| Feb. 6, 2026 | CEO | 7,412 | $20.62 | Sell | $152,835.44 | |
| Feb. 6, 2026 | CFO | 2,082 | $20.62 | Sell | $42,930.84 | |
| Sept. 8, 2025 | CEO | 157,307 | $16.41 | Sell | $2,581,407.87 | |
| Aug. 18, 2025 | Director | 19,200 | $15.84 | Sell | $304,128.00 | |
| Aug. 15, 2025 | Director | 19,200 | $15.54 | Sell | $298,368.00 | |
| July 16, 2025 | CFO | 1,296 | $9.29 | Sell | $12,039.84 | |
| July 16, 2025 | CEO | 7,534 | $9.29 | Sell | $69,990.86 | |
| Feb. 10, 2025 | Insider | 4,618 | $15.50 | Sell | $71,579.00 | |
| Feb. 10, 2025 | CFO | 3,777 | $15.50 | Sell | $58,543.50 | |
| Feb. 10, 2025 | CEO | 13,288 | $15.50 | Sell | $205,964.00 | |
| June 14, 2024 | CFO | 1,250 | $20.03 | Buy | $25,037.50 | |
| Aug. 9, 2023 | Director | 52,855 | $18.27 | Sell | $965,660.85 | |
| Aug. 2, 2023 | Director | 83,000 | $20.46 | Sell | $1,698,180.00 | |
| July 10, 2023 | Director | 52,855 | $20.40 | Sell | $1,078,242.00 | |
| June 13, 2023 | CFO | 577 | $22.31 | Sell | $12,872.87 | |
| June 9, 2023 | Director | 52,855 | $21.18 | Sell | $1,119,468.90 | |
| May 9, 2023 | Director | 52,855 | $21.41 | Sell | $1,131,625.55 | |
| April 10, 2023 | Director | 52,855 | $19.53 | Sell | $1,032,258.15 | |
| March 13, 2023 | Insider | 52,854 | $22.53 | Sell | $1,190,800.62 | |
| Feb. 15, 2023 | insider | 25,000 | $25.84 | Sell | $646,000.00 | |
| Feb. 6, 2023 | CEO | 5,959 | $27.64 | Sell | $164,706.76 | |
| Feb. 6, 2023 | Insider | 52,854 | $26.83 | Sell | $1,418,072.82 | |
| Jan. 12, 2023 | Director | 24,000 | $26.74 | Sell | $641,760.00 | |
| Dec. 1, 2022 | Insider | 7,800 | $25.01 | Sell | $195,078.00 | |
| Oct. 6, 2022 | Director | 29,899 | $25.90 | Sell | $774,384.10 | |
| Oct. 6, 2022 | CEO | 16,231 | $25.29 | Sell | $410,481.99 | |
| Oct. 4, 2022 | CEO | 1,280 | $25.02 | Sell | $32,025.60 | |
| Oct. 3, 2022 | Director | 180 | $25.00 | Sell | $4,500.00 | |
| Sept. 30, 2022 | CEO | 29,606 | $25.02 | Sell | $740,742.12 | |
| Sept. 30, 2022 | Director | 3,561 | $25.07 | Sell | $89,274.27 | |
| Sept. 20, 2022 | Insider | 59,649 | $23.25 | Sell | $1,386,839.25 | |
| Sept. 16, 2022 | Director | 11,975 | $23.43 | Sell | $280,574.25 | |
| Sept. 15, 2022 | Insider | 66,775 | $24.20 | Sell | $1,615,955.00 | |
| Aug. 24, 2022 | Insider | 25,000 | $25.04 | Sell | $626,000.00 | |
| July 25, 2022 | CEO | 31,602 | $21.06 | Sell | $665,538.12 | |
| July 7, 2022 | CEO | 100 | $21.00 | Sell | $2,100.00 | |
| July 1, 2022 | Insider | 62,292 | $19.00 | Sell | $1,183,548.00 | |
| April 4, 2022 | Insider | 3,128 | $18.29 | Sell | $57,211.12 | |
| April 1, 2022 | Insider | 101,045 | $17.45 | Sell | $1,763,235.25 | |
| Feb. 1, 2022 | CAO | 968 | $16.65 | Sell | $16,117.20 | |
| Feb. 1, 2022 | Insider | 1,412 | $16.65 | Sell | $23,509.80 | |
| Dec. 22, 2021 | Director | 24,000 | $22.01 | Sell | $528,240.00 | |
| Dec. 20, 2021 | COO | 61,000 | $20.29 | Sell | $1,237,690.00 | |
| Dec. 20, 2021 | Director | 20,000 | $21.01 | Sell | $420,200.00 | |
| Dec. 17, 2021 | CEO | 35,156 | $20.00 | Sell | $703,120.00 | |
| Dec. 17, 2021 | COO | 1,676 | $19.02 | Sell | $31,877.52 | |
| Dec. 13, 2021 | COO | 36,609 | $19.05 | Sell | $697,401.45 | |
| Nov. 18, 2021 | Director | 14,030 | $18.03 | Sell | $252,960.90 |
Insiders are both buying and selling Syndax Pharmaceuticals Inc stock.
The insider traders at Syndax Pharmaceuticals Inc are: Michael A Metzger, Briggs Morrison, Peter Ordentlich, Keith A Goldan, Dennis Podlesak, Keith Katkin, Pierre Legault, Michael L Meyers, William Meury, Fabrice Egros, Ivor Royston, Neil Gallagher, and Alexander Nolte
The most active insider trader at Syndax Pharmaceuticals Inc is Michael A Metzger with 19 trades.
Briggs Morrison has sold the most Syndax Pharmaceuticals Inc stock with a total value of $17,022,856.70.
Ivor Royston has bought the most Syndax Pharmaceuticals Inc stock with a total value of $3,600,000.00.
The most recent insider trade for Syndax Pharmaceuticals Inc was on Feb. 9, 2026.
The single biggest insider buy for Syndax Pharmaceuticals Inc was from Ivor Royston with a total value of $1,800,000.00 on March 8, 2016.
The single biggest insider sell for Syndax Pharmaceuticals Inc was from Michael A Metzger with a total value of $2,581,407.87 on Sept. 8, 2025.
